Bayer props up sagging radionuclide business with Noria acquisitionBayer has agreed to buy Noria Therapeutics and its subsidiary PSMA Therapeutics, adding to its pipeline of radionuclide Share XBayer props up sagging radionuclide business with Noria acquisitionhttps://pharmaphorum.com/news/bayer-props-up-sagging-radionuclide-business-with-noria-acquisition/
